Immunotherapy
FDA approves Bavencio for first-line maintenance of advanced bladder cancer
The FDA approved avelumab for the first-line maintenance treatment of locally advanced or metastatic urothelial carcinoma, according to a press release from the manufacturer.
Society for Immunotherapy of Cancer names fellowship, award recipients
Adjuvant immunotherapy extends OS for certain patients with stage III melanoma
Adjuvant immunotherapy conferred a significant OS benefit among patients with resected stage IIIC melanoma, according to study results presented at American Association for Cancer Research Virtual Annual Meeting II.
Vitamin D may reduce risk for immune checkpoint inhibitor-induced colitis
Use of vitamin D supplements appeared to reduce risk for colitis among patients with cancer treated with immune checkpoint inhibitors, according to results of a retrospective study published in Cancer.
VIDEO: Integrating study findings into clinical practice ‘remains to be seen’
A number of presentations during this year’s ASCO20 Virtual Scientific Program featured data on the efficacy and safety of immunotherapy combinations for the treatment of metastatic non-small cell lung cancer.
VIDEO: ASCO 2020 featured ‘practice changing’ lung cancer presentations
In this video, Jyoti D. Patel, MD, associate vice chair for clinical research and professor of medicine at Northwestern’s Feinberg School of Medicine, spoke with Healio about presentations in lung cancer being presented at the virtual ASCO Annual Meeting.
Multisite SBRT may make immunotherapy more effective in lung cancer
Multisite stereotactic body radiotherapy, or SBRT, in combination with concurrent ipilimumab and nivolumab was well-tolerated in patients with stage 4 non-small cell lung cancer, according to findings from the COSINR study presented at the virtual ASCO Annual Meeting.
FDA grants fast track designation to vaccine-enhanced cell therapy for glioblastoma
The FDA granted fast track designation to TVI-Brain-1, an adoptive T cell therapy for the treatment of glioblastoma multiforme, according to the agent’s manufacturer.
Better understanding of lung cancer led to plethora of new treatments
Researchers are learning more about the underpinnings of lung cancer cells that control their growth and spread, according to the American Cancer Society.